278 related articles for article (PubMed ID: 34789152)
1. Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study.
Veziris N; Andréjak C; Bouée S; Emery C; Obradovic M; Chiron R
BMC Infect Dis; 2021 Nov; 21(1):1165. PubMed ID: 34789152
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.
Izumi K; Morimoto K; Hasegawa N; Uchimura K; Kawatsu L; Ato M; Mitarai S
Ann Am Thorac Soc; 2019 Mar; 16(3):341-347. PubMed ID: 30339468
[TBL] [Abstract][Full Text] [Related]
3. Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease.
Prevots DR; Marras TK; Wang P; Mange KC; Flume PA
Chest; 2021 Dec; 160(6):2042-2050. PubMed ID: 34314672
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.
Cadelis G; Ducrot R; Bourdin A; Rastogi N
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005841. PubMed ID: 28787454
[TBL] [Abstract][Full Text] [Related]
5. Burden of non-tuberculous mycobacterial pulmonary disease in Germany.
Diel R; Jacob J; Lampenius N; Loebinger M; Nienhaus A; Rabe KF; Ringshausen FC
Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28446559
[TBL] [Abstract][Full Text] [Related]
6. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
[TBL] [Abstract][Full Text] [Related]
7. Clinically refined epidemiology of nontuberculous mycobacterial pulmonary disease in South Korea: overestimation when relying only on diagnostic codes.
Park JH; Shin S; Kim TS; Park H
BMC Pulm Med; 2022 May; 22(1):195. PubMed ID: 35562714
[TBL] [Abstract][Full Text] [Related]
8. Gastroesophageal Reflux Disease Increases Susceptibility to Nontuberculous Mycobacterial Pulmonary Disease.
Kim Y; Yoon JH; Ryu J; Yang B; Chung SJ; Kang HK; Park DW; Park TS; Moon JY; Kim TH; Kim SH; Sohn JW; Yoon HJ; Lee H; Choi H
Chest; 2023 Feb; 163(2):270-280. PubMed ID: 36087796
[TBL] [Abstract][Full Text] [Related]
9. Age- and sex-related characteristics of the increasing trend of nontuberculous mycobacteria pulmonary disease in a tertiary hospital in South Korea from 2006 to 2016.
Park Y; Kim CY; Park MS; Kim YS; Chang J; Kang YA
Korean J Intern Med; 2020 Nov; 35(6):1424-1431. PubMed ID: 32550717
[TBL] [Abstract][Full Text] [Related]
10. Predictive modeling of nontuberculous mycobacterial pulmonary disease epidemiology using German health claims data.
Ringshausen FC; Ewen R; Multmeier J; Monga B; Obradovic M; van der Laan R; Diel R
Int J Infect Dis; 2021 Mar; 104():398-406. PubMed ID: 33444748
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of infection by pulmonary non-tuberculous mycobacteria in French Guiana 2008-2018.
Chaptal M; Andrejak C; Bonifay T; Beillard E; Guillot G; Guyomard-Rabenirina S; Demar M; Trombert-Paolantoni S; Jacomo V; Mosnier E; Veziris N; Djossou F; Epelboin L;
PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010693. PubMed ID: 36084148
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis.
Uno S; Asakura T; Morimoto K; Yoshimura K; Uwamino Y; Nishimura T; Hoshino Y; Hasegawa N;
BMC Pulm Med; 2020 Oct; 20(1):262. PubMed ID: 33036598
[TBL] [Abstract][Full Text] [Related]
13. Reduction in Expected Survival Associated With Nontuberculous Mycobacterial Pulmonary Disease.
Mourad A; Baker AW; Stout JE
Clin Infect Dis; 2021 May; 72(10):e552-e557. PubMed ID: 32856690
[TBL] [Abstract][Full Text] [Related]
14. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
[TBL] [Abstract][Full Text] [Related]
15. Non-tuberculous mycobacteria: epidemiological pattern in a reference laboratory and risk factors associated with pulmonary disease.
Mencarini J; Cresci C; Simonetti MT; Truppa C; Camiciottoli G; Frilli ML; Rogasi PG; Veloci S; Pistolesi M; Rossolini GM; Bartoloni A; Bartalesi F
Epidemiol Infect; 2017 Feb; 145(3):515-522. PubMed ID: 27804902
[TBL] [Abstract][Full Text] [Related]
16. The Higher Incidence of COVID-19 in Patients With Non-Tuberculous Mycobacterial Pulmonary Disease: A Single Center Experience in Korea.
Kim SH; Jhun BW; Jeong BH; Park HY; Kim H; Kwon OJ; Shin SH
J Korean Med Sci; 2022 Aug; 37(32):e250. PubMed ID: 35971764
[TBL] [Abstract][Full Text] [Related]
17. High incidence of non-tuberculous mycobacteria-positive cultures among adolescent with cystic fibrosis.
Cavalli Z; Reynaud Q; Bricca R; Nove-Josserand R; Durupt S; Reix P; Perceval M; de Montclos MP; Lina G; Durieu I
J Cyst Fibros; 2017 Sep; 16(5):579-584. PubMed ID: 28202251
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016.
Tan Y; Su B; Shu W; Cai X; Kuang S; Kuang H; Liu J; Pang Y
BMC Pulm Med; 2018 Nov; 18(1):168. PubMed ID: 30413193
[TBL] [Abstract][Full Text] [Related]
19. Mortality association of nontuberculous mycobacterial infection requiring treatment in Taiwan: a population-based study.
Chen HH; Lin CH; Chao WC
Ther Adv Respir Dis; 2022; 16():17534666221103213. PubMed ID: 35748569
[TBL] [Abstract][Full Text] [Related]
20. Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis.
Eikani MS; Nugent M; Poursina A; Simpson P; Levy H
BMC Infect Dis; 2018 Jul; 18(1):311. PubMed ID: 29980189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
